Form 4: Emergent BioSolutions SVP Disposes Shares for Tax Obligations Related to RSU Vesting

Paul Anthony Williams, SVP of Products Business at Emergent BioSolutions Inc., reported the disposition of 464 common shares to cover tax liabilities related to restricted stock unit vesting.

Summary

• Paul Anthony Williams, the Senior Vice President of Products Business at Emergent BioSolutions Inc. (EBS), filed a Form 4 reporting a transaction on June 8, 2025.
• The transaction involved the disposition of 464 shares of Emergent BioSolutions common stock.
• These shares were withheld by the issuer at a price of $6.63 per share to satisfy tax obligations associated with the vesting and settlement of restricted stock units (RSUs).
• Following this reported transaction, Mr. Williams directly beneficially owns 85,871 shares of Emergent BioSolutions common stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax withholding event related to RSU vesting, which is a neutral event. It reflects the settlement of previously granted equity compensation rather than a discretionary sale or purchase.

Positives

• The transaction indicates the vesting of previously granted restricted stock units, which is a common form of executive compensation designed to align management interests with shareholder value.
• The disposition of shares for tax withholding is a routine and expected event, demonstrating compliance with tax obligations related to equity compensation.

Negatives

• The disposition of shares, even for tax purposes, results in a minor reduction in the executive's direct ownership stake in the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information relevant to broader industry trends or competitive analysis. It reflects standard executive compensation practices within the biotechnology and pharmaceutical sectors, where restricted stock units are a common form of equity incentive.

Stakeholder Impact

• Shareholders: The disposition of a small number of shares for tax purposes by an executive is a routine event and is unlikely to have a significant direct impact on the share price or shareholder value. It confirms the executive's continued equity ownership.
• Employees: No direct impact on employees is indicated.
• Customers: No direct impact on customers is indicated.
• Suppliers: No direct impact on suppliers is indicated.
• Creditors: No direct impact on creditors is indicated.

Key Dates

Keywords

Emergent BioSolutions, EBS, Paul Anthony Williams, Form 4, SEC filing, Insider transaction, Stock disposition, Restricted Stock Units, RSU vesting, Tax withholding, Executive compensation